BAM
INFI

Blueshift Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Blueshift Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,609
Closed -$74K – 1309
2021
Q3 		$74K Buy
+21,609
New +$66.6K ﹤0.01% 967

Other funds holding INFI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Blueshift Asset Management's INFI Position: Q4 2021 in Review

Blueshift Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 21,609 shares — an estimated $74K sold.

Blueshift Asset Management first reported a position in INFI in Q3 2021 and held it in 1 quarter. The position peaked at $74K in Q3 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

  • Blueshift Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 21,609 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $74K.
  • Blueshift Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
  • Blueshift Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $74K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on Blueshift Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.